Literature DB >> 19179432

Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Edith Sánchez1, Miguel Angel Vargas, Praful S Singru, Isel Pascual, Fidelia Romero, Csaba Fekete, Jean-Louis Charli, Ronald M Lechan.   

Abstract

Pyroglutamyl peptidase II (PPII), a highly specific membrane-bound metallopeptidase that inactivates TRH in the extracellular space, is tightly regulated by thyroid hormone in cells of the anterior pituitary. Whether PPII has any role in the region where axons containing hypophysiotropic TRH terminate, the median eminence, is unknown. For this purpose, we analyzed the cellular localization and regulation of PPII mRNA in the mediobasal hypothalamus in adult, male rats. PPII mRNA was localized in cells lining the floor and infralateral walls of the third ventricle and coexpressed with vimentin, establishing these cells as tanycytes. PPII mRNA extended in a linear fashion from the tanycyte cell bodies in the base of the third ventricle to its cytoplasmic and end-feet processes in the external zone of the median eminence in close apposition to pro-TRH-containing axon terminals. Compared with vehicle-treated, euthyroid controls, animals made thyrotoxic by the i.p. administration of 10 microg L-T(4) daily for 1-3 d, showed dramatically increased accumulation of silver grains in the mediobasal hypothalamus and an approximately 80% increase in enzymatic activity. PPII inhibition in mediobasal hypothalamic explants increased TRH secretion, whereas i.p. injection of a specific PPII inhibitor increased cold stress- and TRH-induced TSH levels in plasma. We propose that an increase in circulating thyroid hormone up-regulates PPII activity in tanycytes and enhances degradation of extracellular TRH in the median eminence through glial-axonal associations, contributing to the feedback regulation of thyroid hormone on anterior pituitary TSH secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179432      PMCID: PMC2671897          DOI: 10.1210/en.2008-1643

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  54 in total

1.  Characterization of a thyroliberin-degrading serum enzyme catalyzing the hydrolysis of thyroliberin at the pyroglutamyl-histidine bond.

Authors:  K Bauer; P Nowak
Journal:  Eur J Biochem       Date:  1979-09

2.  A second look at the barriers of the medial basal hypothalamus.

Authors:  B Peruzzo; F E Pastor; J L Blázquez; K Schöbitz; B Peláez; P Amat; E M Rodríguez
Journal:  Exp Brain Res       Date:  2000-05       Impact factor: 1.972

3.  Ultrastructural localization of vimentin immunoreactivity and gene expression in tanycytes and their alterations in hamsters kept under different photoperiods.

Authors:  Yoko Kameda; Yuta Arai; Toshiyuki Nishimaki
Journal:  Cell Tissue Res       Date:  2003-09-09       Impact factor: 5.249

4.  Differential actions of thyrotropin (TSH)-releasing hormone pulses in the expression of prolactin and TSH subunit messenger ribonucleic acid in rat pituitary cells in vitro.

Authors:  D J Haisenleder; G A Ortolano; A C Dalkin; M Yasin; J C Marshall
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

5.  Regulation of degradation of thyrotropin releasing hormone by thyroid hormones.

Authors:  K Bauer
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

6.  Effect of neurotransmitters on the in vitro release of immunoreactive thyrotropin-releasing hormone from rat mediobasal hypothalamus.

Authors:  P Joseph-Bravo; J L Charli; J M Palacios; C Kordon
Journal:  Endocrinology       Date:  1979-03       Impact factor: 4.736

7.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

8.  Purification and characterization of the thyrotropin-releasing hormone (TRH)-degrading serum enzyme and its identification as a product of liver origin.

Authors:  Stephanie Schmitmeier; Hubert Thole; Augustinus Bader; Karl Bauer
Journal:  Eur J Biochem       Date:  2002-02

9.  Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain.

Authors:  Isel Pascual; Shirley Gil-Parrado; Miguel Cisneros; Patricia Joseph-Bravo; Joaquín Díaz; Lourival D Possani; Jean Louis Charli; María Chávez
Journal:  Int J Biochem Cell Biol       Date:  2004-01       Impact factor: 5.085

10.  Morphological aspects of the hypothalamic-hypophyseal system. VII. The tanycytes: Their relation to the hypophyseal adrenocorticotrophic function. An ultrastructural study.

Authors:  I G Akmayev; A P Popov
Journal:  Cell Tissue Res       Date:  1977-05-16       Impact factor: 5.249

View more
  29 in total

1.  Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration.

Authors:  Edith Sánchez; Praful S Singru; Gábor Wittmann; Shira S Nouriel; Perry Barrett; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

3.  Thyroid hormone regulation by stress and behavioral differences in adult male rats.

Authors:  Dana L Helmreich; Daniel Tylee
Journal:  Horm Behav       Date:  2011-06-12       Impact factor: 3.587

4.  The LIM homeodomain factor Lhx2 is required for hypothalamic tanycyte specification and differentiation.

Authors:  Juan Salvatierra; Daniel A Lee; Cristina Zibetti; Maria Duran-Moreno; Sooyeon Yoo; Elizabeth A Newman; Hong Wang; Joseph L Bedont; Jimmy de Melo; Ana L Miranda-Angulo; Sara Gil-Perotin; Jose Manuel Garcia-Verdugo; Seth Blackshaw
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

Review 5.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

6.  Gene expression analysis and microdialysis suggest hypothalamic triiodothyronine (T3) gates daily torpor in Djungarian hamsters (Phodopus sungorus).

Authors:  Jonathan H H Bank; Ceyda Cubuk; Dana Wilson; Eddy Rijntjes; Julia Kemmling; Hanna Markovsky; Perry Barrett; Annika Herwig
Journal:  J Comp Physiol B       Date:  2017-04-01       Impact factor: 2.200

7.  Understanding the hypothalamus-pituitary-thyroid axis in mct8 deficiency.

Authors:  Julia Müller; Heike Heuer
Journal:  Eur Thyroid J       Date:  2012-06-20

8.  Evidence Supporting a Role for the Blood-Cerebrospinal Fluid Barrier Transporting Circulating Ghrelin into the Brain.

Authors:  Maia Uriarte; Pablo Nicolás De Francesco; Gimena Fernandez; Agustina Cabral; Daniel Castrogiovanni; Tyler Lalonde; Leonard G Luyt; Sebastian Trejo; Mario Perello
Journal:  Mol Neurobiol       Date:  2018-10-02       Impact factor: 5.590

Review 9.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

10.  Family members CREB and CREM control thyrotropin-releasing hormone (TRH) expression in the hypothalamus.

Authors:  Franck Chiappini; Preeti Ramadoss; Kristen R Vella; Lucas L Cunha; Felix D Ye; Ronald C Stuart; Eduardo A Nillni; Anthony N Hollenberg
Journal:  Mol Cell Endocrinol       Date:  2012-09-20       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.